To be considered for tirzepatide treatment, clients should meet the following requirements: A Body Mass Index (BMI) of 30 kg/m or higher, qualifying as obesity, or a BMI of 27 kg/m or higher if accompanied by at least one weight-related health condition, such as Type 2 diabetes, hypertension, dyslipidemia (high cholesterol or triglycerides), obstructive sleep apnea, or nonalcoholic fatty liver disease (NAFLD)
Many patients come to PEAK specifically because they want to move from a telehealth-only prescription to a clinician-managed program with nutritional support
Compounded medications are custom-mixed versions of FDA-approved drugs, produced by specialized pharmacies called 503B outsourcing facilities
Key Takeaways Eli Lilly is launching singe-use vials of its popular weight-loss drug Zepbound, which will be half the price of previous versions of the drug
Post-Surgical GI Factors and Tirzepatide Compatibility Assessment Before starting tirzepatide, patients without a gallbladder should discuss their post-surgical symptoms, current GI medications, and bile acid handling with their provider
John Roxborough, MD , and our team are here to help you understand the differences between these medications and choose the one thats right for you